Reports & Presentations
Subsidiary Financials 2020 - 21
- Glenmark Holding SA La Chaux-de-Fonds
- Glenmark Dominicana SRL
- Glenmark Pharmaceuticals Egypt S.A.E.
- Glenmark Pharmaceuticals Colombia SAS, Colombia
- Glenmark Pharmaceuticals FZE
- Glenmark Pharmaceuticals (Australia) Pty Ltd
- Glenmark Pharmaceuticals Kenya Ltd
- Glenmark Pharmaceuticals Malaysia Sdn Bhd
- Glenmark Pharmaceuticals B.V.
- Glenmark Pharmaceuticals Distribution s.r.o.
- Glenmark Pharmaceuticals Europe Ltd.
- Glenmark Pharmaceuticals (Europe) R&D Ltd.
- Glenmark Pharmaceuticals Singapore Pte. Ltd.
- Glenmark Pharmaceuticals S.R.O.
- Glenmark Philippines Inc.
- Glenmark Pharmaceuticals (Thailand) Co. Ltd.
- Glenmark Pharmaceuticals (Nigeria) Ltd
- Glenmark Pharmaceuticals Venezuela, C.A
- Glenmark South Africa Proprietary Limited
- Glenmark Pharmaceuticals South Africa Proprietary Limited
- Glenmark Life Sciences Limited
- Glenmark Arzneimittel GmbH
- Glenmark Farmaceutica Ltda
- GLENMARK PHARMACEUTICALS SP. Z O.O
- VISO Farmaceutica S.L.U
- Glenmark Pharmaceuticals SK SRO
- Glenmark Pharmaceuticals Inc.
- Glenmark Uruguay S.A.
- Glenmark Pharmaceuticals Canada Inc.
- Glenmark Pharmaceuticals Nordic AB
- Glenmark Ukraine LLC
